Skip to main content

NeuBase Therapeutics, Inc.

NBSEDelisted May 16, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001173281

NeuBase Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Sep 18, 2023; 18 institutions reported holding it in 13F filings for Q1 2024, worth $177.1K in total; Greenlight Capital was the only superinvestor holding it.

13F holders, Q2 2023

Institutional positions in NeuBase Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
26
−10 vs. Q1 2023
Shares held
578.9K
+115.0K (+24.8%) vs. Q1 2023Converted for a 1-for-20 split
Total value
$1.08M
−$634.6K (−37.0%) vs. Q1 2023
New holders
5
3 more added
Sold out
15
7 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NBSE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 26 institutions
Q1 2021: 57 institutionsQ2 2021: 59 institutionsQ3 2021: 48 institutionsQ4 2021: 46 institutionsQ1 2022: 45 institutionsQ2 2022: 43 institutionsQ3 2022: 44 institutionsQ4 2022: 35 institutionsQ1 2023: 36 institutionsQ2 2023: 26 institutionsQ3 2023: 20 institutionsQ4 2023: 21 institutionsQ1 2024: 18 institutionsQ2 2024: 2 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $1.08M
Q1 2021: $59.4MQ2 2021: $51.5MQ3 2021: $36.6MQ4 2021: $31.6MQ1 2022: $23.3MQ2 2022: $13.4MQ3 2022: $4.74MQ4 2022: $1.94MQ1 2023: $1.72MQ2 2023: $1.08MQ3 2023: $301.2KQ4 2023: $340.2KQ1 2024: $177.1KQ2 2024: $4.95KQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding NBSE and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20242$4.95K
Q1 202418$177.1K
Q4 202321$340.2K
Q3 202320$301.2K
Q2 202326$1.08M
Q1 202336$1.72M
Q4 202235$1.94M
Q3 202244$4.74M
Q2 202243$13.4M
Q1 202245$23.3M
Q4 202146$31.6M
Q3 202148$36.6M
Q2 202159$51.5M
Q1 202157$59.4M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding NeuBase Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding NBSE in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC166,174$310.7K0.01%+166,174New
Greenlight Capital Inc136,350$255.0K0.01%00.0%UnchangedConverted for a 1-for-20 split
Point72 Asset Management, L.P.62,500$116.9K0.00%00.0%UnchangedConverted for a 1-for-20 split
Decheng Capital Management III (Cayman), LLC50,000$92.5K0.03%00.0%UnchangedConverted for a 1-for-20 split
Carnegie Mellon University46,970$87.8K0.12%00.0%UnchangedConverted for a 1-for-20 split
Kestra Advisory Services, LLC25,483$47.7K0.00%00.0%UnchangedConverted for a 1-for-20 split
Vanguard Group Inc18,981$35.5K0.00%+143+0.8%AddedConverted for a 1-for-20 split
Prelude Capital Management, LLC15,550$29.1K0.00%00.0%UnchangedConverted for a 1-for-20 split
Jacob Asset Management of New York LLC15,655$29.0K0.03%00.0%UnchangedConverted for a 1-for-20 split
Renaissance Technologies LLC12,601$24.0K0.00%+3,970+46.0%AddedConverted for a 1-for-20 split
Geode Capital Management, LLC11,696$21.6K0.00%00.0%UnchangedConverted for a 1-for-20 split
Tower Research Capital LLC (TRC)7,815$14.6K0.00%+6,926+779.2%AddedConverted for a 1-for-20 split
CM Management, LLC6,000$11.0K0.01%00.0%UnchangedConverted for a 1-for-20 split
Bank of America Corp804$1.50K0.00%−1,894−70.2%ReducedConverted for a 1-for-20 split
First Manhattan Co706$1.32K0.00%00.0%UnchangedConverted for a 1-for-20 split
Royal Bank of Canada283$1.00K0.00%+283New
JPMorgan Chase & Co539$9970.00%+539New
BlackRock Inc.464$8680.00%−3,355−87.8%ReducedConverted for a 1-for-20 split
IFP Advisors, Inc105$4690.00%+105New
UBS Group AG68$1270.00%−118−63.5%ReducedConverted for a 1-for-20 split
Wells Fargo & Company62$1160.00%00.0%UnchangedConverted for a 1-for-20 split
Advisor Group Holdings, Inc.22$410.00%−1−2.2%ReducedConverted for a 1-for-20 split
The PNC Financial Services Group, Inc.21$390.00%−0−1.6%ReducedConverted for a 1-for-20 split
Newbridge Financial Services Group, Inc.12$220.00%−1−4.0%ReducedConverted for a 1-for-20 split
Global Wealth Management Investment Advisory, Inc.12$220.00%+12New
Morgan Stanley7$130.00%−1−6.7%ReducedConverted for a 1-for-20 split
Polar Asset Management Partners Inc.0$00.00%−31,731−100.0%Sold outConverted for a 1-for-20 split
Perkins Capital Management Inc0$00.00%−6,625−100.0%Sold outConverted for a 1-for-20 split
Waldron Private Wealth LLC0$00.00%−3,981−100.0%Sold outConverted for a 1-for-20 split
State Street Corp0$00.00%−3,434−100.0%Sold outConverted for a 1-for-20 split
Northern Trust Corp0$00.00%−2,746−100.0%Sold outConverted for a 1-for-20 split
Virtu Financial LLC0$00.00%−2,031−100.0%Sold outConverted for a 1-for-20 split
Davenport & Co LLC0$00.00%−1,500−100.0%Sold outConverted for a 1-for-20 split
Charles Schwab Investment Management Inc0$00.00%−1,486−100.0%Sold outConverted for a 1-for-20 split
Two Sigma Securities, LLC0$00.00%−1,158−100.0%Sold outConverted for a 1-for-20 split
Susquehanna International Group, LLP0$00.00%−963−100.0%Sold outConverted for a 1-for-20 split
Mariner, LLC0$00.00%−775−100.0%Sold outConverted for a 1-for-20 split
Wealthsource Partners, LLC0$00.00%−700−100.0%Sold outConverted for a 1-for-20 split
Jane Street Group, LLC0$00.00%−517−100.0%Sold outConverted for a 1-for-20 split
Ritter Daniher Financial Advisory LLC0$00.00%−0−100.0%Sold outConverted for a 1-for-20 split
Simplex Trading, LLC0$00.00%−86−100.0%Sold outConverted for a 1-for-20 split